Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
28.00
+0.15 (0.54%)
Aug 1, 2025, 4:00 PM - Market closed

HRTS Holdings Information

HRTS is an equity ETF with a total of 43 individual holdings. The top holdings are Eli Lilly and Company stock at 9.90%, Abbott Laboratories at 4.73%, AstraZeneca at 4.45%, Roche Holding AG at 4.11%, and UnitedHealth Group at 3.88%.

Total Holdings
43
Top 10 Percentage
44.18%
Asset Class
Equity
ETF Category
Health
Assets
47.90M
PE Ratio
21.59

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company9.90%6,215
2ABTAbbott Laboratories4.73%17,577
3LON: AZNAstraZeneca PLC4.45%13,951
4RHHBYRoche Holding AG4.11%48,924
5UNHUnitedHealth Group Incorporated3.88%6,953
6GILDGilead Sciences, Inc.3.56%14,795
7MDTMedtronic plc3.53%18,358
8TMOThermo Fisher Scientific Inc.3.37%3,369
9BSXBoston Scientific Corporation3.34%14,910
10BBIOBridgeBio Pharma, Inc.3.33%34,808
11ABBVAbbVie Inc.3.33%8,383
12CPH: NOVO.BNovo Nordisk A/S3.22%30,869
13SWX: NOVNNovartis AG3.17%12,936
14VRTXVertex Pharmaceuticals Incorporated2.84%2,887
15AMGNAmgen Inc.2.67%4,230
16CRNXCrinetics Pharmaceuticals, Inc.2.60%42,505
17MRKMerck & Co., Inc.2.54%14,811
18DHRDanaher Corporation2.40%5,616
19TYO: 4519Chugai Pharmaceutical Co., Ltd.2.28%21,921
20REGNRegeneron Pharmaceuticals, Inc.2.14%1,838
21PODDInsulet Corporation2.12%3,394
22BMYBristol-Myers Squibb Company2.03%21,064
23MCKMcKesson Corporation1.97%1,315
24EWEdwards Lifesciences Corporation1.94%11,435
25ALNYAlnylam Pharmaceuticals, Inc.1.91%2,687
As of Jul 30, 2025
Showing 25 of 43
Subscribe to see the full list